Description

Atropin (Atropine Sulfate) Ampoules 0.1% 1ml. №10

Ingredients

Each ampoule contains: Atropine sulfate 1mg in 1ml solution.

Dosage

The usual dose: 0.5 to 1ml (0.5 to 1mg of atropine sulfate) injected subcutaneously or intramuscularly.

Indications

Atropin ampoules are indicated for bradycardia, organophosphate poisoning, and as a pre-anesthetic to reduce salivation.

Contraindications

Do not use Atropin ampoules in patients with glaucoma, obstructive uropathy, or myasthenia gravis.

Directions

Administer Atropin ampoules as directed by a healthcare professional. Do not exceed the recommended dose.

Scientific Evidence

Studies have shown that atropine sulfate, the active ingredient in Atropin ampoules, effectively increases heart rate in cases of bradycardia and reverses the muscarinic effects of organophosphate poisoning.

Additional Information

Storage: Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Protect from light.

Pharmacological Effects: Atropine sulfate acts as a competitive antagonist of acetylcholine at muscarinic receptors, leading to increased heart rate, bronchodilation, and decreased secretions. This mechanism of action makes it valuable in various clinical settings.

Clinical Trials: Clinical trials have demonstrated the efficacy of atropine sulfate in the management of bradycardia and organophosphate poisoning. Research published in the Journal of Emergency Medicine highlighted the role of atropine in improving outcomes in these conditions.